About Us

Who we are

Cytognos is a Biotech company based in Salamanca with over 20 years of experience at successfully designing, developing, manufacturing and commercializing innovative flow cytometry products for in vitro diagnostics (IVD) and life science research use only (RUO). Cytognos´ growth strategy has been based on bringing to the market exclusive technologies transferred by research centres and universities, these innovative products have allowed Cytognos to become a reference point, providing world-class products developed to address gaps within the current multicolour flow cytometry workflow.

Cytognos collaborates actively with the EuroFlow™ consortium implementing and bringing onto the market the Next Generation Flow™ approach which provides high sensitive flow cytometry tests and standardized protocols for the diagnosis, classification and follow-up of haematological malignancies, Minimal Residual Disease detection and Primary Immunodeficiencies.

Mission and Vision

MissionVision

Quality

Cytognos S.L is certified by the ISO 13485 for Medical Devices, therefore we offer the best quality products and guarantee compliance with the applicable regulatory requirements.

Our certification by ISO 9001 allows us to keep improving products, achieve customer’s satisfaction and meet any requirement of our stakeholders. Products and services given by external suppliers might affect directly our company activity. For this reason, Cytognos S.L informs suppliers that they will be evaluated. This evaluation will be based on specific criteria previously defined according to a risk assessment performed by Cytognos. Also, Cytognos will monitor suppliers continuously as well as their compliance based on defined requirements for ordered products and/or services.

These certificates and our Quality Policy are available below:

  • ISO 9001 Quality Management Systems. Requirements
  • ISO 13485 Medical Devices. Quality Management Systems. Requirements for regulatory purposes
  • Quality Policy

Our history

1996. Foundation

Cytognos was founded in 1996 within the Hematology Department at the University of Salamanca.

1999. Grupo Vitro

In 1999, Cytognos joined one of the Spain’s largest companies in the diagnosis field, Grupo Vitro.

2006. EuroFlow™

In 2006, Cytognos became part of the EuroFlow™ Consortium and started the development of Infinicyt™, our software for flow cytometry data analysis.

2010. Multicolor cocktails

In 2010, we started the commercialization of panels for clinical diagnosis. These panels follow the EuroFlow™ protocols and are available as commercial kits in lyophilized format, containing all antibodies required in each panel.

2017. Automated Data Analysis

In 2017, we launched an automated analysis new tool based on patient data databases. For the first time ever, a product like this was used in hematology laboratories.

2018. CE-IVD Flow Cytometer

In 2018, we completed our products offer with the Next Generation Flow™ flow cytometer Omnicyt™.

2022. Cytognos Acquisition

In 2022, Cytognos was acquired by BD Biosciences.

Staff

Cytognos is composed of more than 65 highly qualified employees from multiple nationalities.

Our I+D department unites knowledge and experience and plays an important role in the development of all our products and the optimization of protocols and instrument set up.

Our Technical Support team is well trained in flow cytometry and currently provides support to customers and distributors in more than 54 countries around the world.

Values

  • Innovation
  • Commitment
  • Effort
  • Excellence
  • Involvement